Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray doses for preoperative anxiety in spinal anesthesia
ChiCTR2500107195Phase 4Not yet recruiting
- Sponsor
- Wuhan Third Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in preoperative anxiety (3 arms), sponsored by Wuhan Third Hospital. Primary endpoints: Ramsay score, Total sleep duration and 2 more. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2500107195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107195.